Lawyers Annemarie Lagger

Annemarie Lagger

Annemarie Lagger

Managing Associate
M.A. HSG in Law, M.A. HSG in International Affairs and Governance, Attorney at Law

Location

Contact

Direct phone: +41 58 658 51 93
annemarie.lagger@walderwyss.com

Curriculum Vitae

Areas of activity: Data & Technology Healthcare & Life Sciences Intellectual Property Litigation

Annemarie Lagger is a managing associate in the team of Regulated Markets, Competition, Technology & IP. She advises in the legal fields of information technology (including e-commerce) and life sciences (including food and drug law). In these areas of legal practice, she sets focus on contract negotiation and drafting (such as outsourcing, development, collaboration, licence and distribution agreements) and on regulatory clearance prior to product and service launches. She represents clients before courts and administrative bodies.

Annemarie Lagger studied International Affairs and Governance at the Universities of Geneva (B.A. 2008), Singapore and St.Gallen (M.A. HSG, 2012) and Law at the University of St.Gallen (M.A. HSG in Law, 2014). Before joining Walder Wyss AG she had gained working experience with NGOs in Canada (2009) and in Ghana (2011). Subsequently, she worked in the legal department of a bulk shipping company in Hamburg (2011-2013). She was admitted to the bar in 2017. Annemarie Lagger publishes on a regular basis.

Annemarie Lagger's professional languages are German, English and French. She is registered with the Zurich Bar Registry and admitted to practice in Switzerland.

Promotions at Walder Wyss

Hitachi ABB Power Grids outsources IT infrastructure services to HCL Technologies

Walder Wyss launches ICT podcast

ABB outsources hosting infrastructure and management services to Tata Consultancy Services (TCS)

Walder Wyss advises global aesthetic manufacturer Teoxane Laboratories on Exclusive U.S. Distribution Agreement of FDA-Approved RHA Dermal Fillers with Revance Therapeutics, Inc.

SEED acquires controlling interest in Sensimed AG

16 December 2019

ImmunOs Therapeutics AG raises CHF 15m in Series A Financing

9 December 2019

Avaloq acquires Derivative Partners, a Zurich-based Service Specialist for Structured Products

24 November 2019

Neuraxpharm Group enters the CBD market with the acquisition of S.T.U. GmbH

30 October 2019

Metall Zug (SIX: METN) acquires majority holding in Haag-Streit Holding AG

21 December 2017

Product Liability & Safety 2024 - Chapter Switzerland

Product Recall 2024 - Chapter Switzerland

Healthcare: Medical Devices 2023 - Chapter Switzerland

27 September 2023

OTT-services: clarity from the Threema ruling?

1 September 2022

Update on Film Act revision: investment obligation and quotas for European films

18 November 2021

Nahrungsergänzungsmittel: Unzulässige Werbung mit dem Wirkstoff CBD. Urteil des Bundesgerichts 2C_733/2020 vom 15. März 2021

31 July 2021

Providers of OTT services qualify as DCPSs

Proposed Film Act revision: investment obligation for online film providers and quotas for European films

21 January 2021

Central Attack against Swiss Basis under the Madrid System Constitutes a Legal Interest in the Invalidity Action

13 January 2021

New requirements for film and video game platforms under proposed youth protection legislation

10 December 2020

Well-known trademarks in the context of a product’s culinary origin

Medicinal Product Names: New Guidance Document

Swissmedic issues guidelines on product names for medicinal products

10 February 2020

Requirements for Foodstuffs and Utility Articles

26 January 2020

Handbook on Foodstuffs and Utility Articles law

31 December 2019

Federal Council offers financial assistance to online media

26 September 2019

Protection of minors in respect of films and video games: consultation process commenced

Highlights of pre-draft Electronic Media Act

21 February 2019

Recognitions

Chambers GPG Product Liability and Safety 2024

Legal500 - EMEA 2024 - Recommended Lawyer

Chambers Healthcare: Medical Devices - Contributer

Other lawyers

Technically necessary cookies

Essential technical cookies are necessary for the flawless functioning of our website and cannot be disabled.
Cookies for statistics

Analytical cookies enable us to count visits and traffic sources, allowing us to measure and enhance the performance of our website. They assist us in answering questions such as which pages are the most popular, which are the least used, and how visitors navigate the website. All information collected by these cookies is aggregated and therefore anonymous.
Marketing cookies may be set by our advertising partners on our website. These companies can use them to create a profile of your interests and display relevant advertisements on other websites. They operate by uniquely identifying your browser and device. By activating these cookies, you acknowledge and consent to the information collected by such cookies being sent to providers outside of Switzerland and the EU, including countries with (from the perspective of Swiss data protection law) inadequate data protection (e.g., the United States, Singapore, and Taiwan). You also acknowledge that data transmitted abroad is no longer protected by Swiss law, and foreign laws as well as regulatory orders may require the disclosure of this data to authorities and other third parties.

Marketing cookies may be set by our advertising partners on our website. These companies can use them to create a profile of your interests and display relevant advertisements on other websites. They operate by uniquely identifying your browser and device. By activating these cookies, you acknowledge and consent to the information collected by such cookies being sent to providers outside of Switzerland and the EU, including countries with (from the perspective of Swiss data protection law) inadequate data protection (e.g., the United States, Singapore, and Taiwan). You also acknowledge that data transmitted abroad is no longer protected by Swiss law, and foreign laws as well as regulatory orders may require the disclosure of this data to authorities and other third parties.